Aethlon Medical Submits Biodefense Contract Proposal to U.S. Government

SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has submitted a contract proposal to a Broad Agency Announcement (BAA) solicitation entitled; “Application of Platform Technologies for the Development of Therapeutic Agents for Biodefense.” The solicitation (DMID-NIAID-NIHAI20080022BARDA) represents a partnership between the National Institute of Allergy and Infectious Diseases (NIAID) and the recently established Biomedical Advanced Research and Development Authority (BARDA) to award contracts that fund the development of innovative approaches to treat bioterror and emerging pandemic threats.

Back to news